CIK 0001854270 · <br>Emerging growth company
Senti Biosciences Holdings, Inc.
Sign in to watch- Ticker
- SNTI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862437900
- Phone
- (650) 239-2030
- Business address
- 2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Senti Biosciences, Inc., Senti Biosciences, Inc.\, Dynamics Special Purpose Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Lu Timothy K CEO and President | Grant or award · Stock Option (Right to Buy) | +630,000 | 630,000 | ||
| 2022-10-03 | KNOBELMAN DEBORAH Chief Financial Officer | Grant or award | +30,000 | 30,000 | ||
| 2022-10-03 | KNOBELMAN DEBORAH Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +240,000 | 240,000 | ||
| 2022-07-18 | Rajangam Kanya Chief Medical & Devt. Officer | Grant or award · Stock Option (Right to Buy) | +327,750 | 327,750 | ||
| 2022-07-13 | Mathers Edward T Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-07-13 | Collins James J. Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-07-13 | Farokhzad Omid Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-07-13 | Berland Susan D Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-07-13 | Epstein David R Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-07-13 | COOPERSTONE BRENDA Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-06-08 | Epstein David R Director | Grant or award | +112,519 | 123,252 | ||
| 2022-06-08 | Epstein David R Director | Option exercise · Class B Common Stock | −112,519 | 0 | ||
| 2022-06-08 | Farokhzad Omid Director | Option exercise | +5,750,000 | 6,465,500 | ||
| 2022-06-08 | Farokhzad Omid Director | Other disposition | −4,518,097 | 1,947,403 | ||
| 2022-06-08 | Farokhzad Omid Director | Grant or award | +250,000 | $10.00 | $2.5M | 250,000 |
| 2022-06-08 | Farokhzad Omid Director | Option exercise · Class B Common Stock | −5,750,000 | 0 | ||
| 2022-06-08 | Dynamics Sponsor LLC Director | Option exercise | +5,750,000 | 6,465,500 | ||
| 2022-06-08 | Dynamics Sponsor LLC Director | Other disposition | −6,465,500 | 0 | ||
| 2022-06-08 | Dynamics Sponsor LLC Director | Option exercise · Class B Common Stock | −5,750,000 | 0 |
Page 4 of 4 · 79 trades